Mouse Anti-DDT Recombinant Antibody (1D5) (V2LY-0425-LY25)

Caltabiano, R., De Pasquale, R., Piombino, E., Campo, G., Nicoletti, F., Cavalli, E., ... & Fagone, P. (2021). Macrophage Migration Inhibitory Factor (MIF) and Its Homologue D-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus. Molecules, 26(1), 184.

Song, S., Liu, B., Habibie, H., van den Bor, J., Smit, M. J., Gosens, R., ... & Melgert, B. N. (2021). D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling. EBioMedicine, 68, 103412.

Illescas, O., Pacheco-Fernández, T., Laclette, J. P., Rodriguez, T., & Rodriguez-Sosa, M. (2020). Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system. Cytokine, 133, 155121.

Cavalli, E., Mazzon, E., Mammana, S., Basile, M. S., Lombardo, S. D., Mangano, K., ... & Petralia, M. C. (2019). Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma. Brain Sciences, 9(10), 284.

Ma, Y., Su, K. N., Pfau, D., Rao, V. S., Wu, X., Hu, X., ... & Young, L. H. (2019). Cardiomyocyte d-dopachrome tautomerase protects against heart failure. JCI insight, 4(17).

Cavalli, E., Mazzon, E., Basile, M. S., Mangano, K., Di Marco, R., Bramanti, P., ... & Petralia, M. C. (2019). Upregulated expression of macrophage migration inhibitory factor, its analogue D-dopachrome tautomerase, and the CD44 receptor in peripheral CD4 T cells from clinically isolated syndrome patients with rapid conversion to clinical defined multiple sclerosis. Medicina, 55(10), 667.

Han, Z., Qu, J., Zhao, J., & Zou, X. (2018). Genetic variant rs755622 regulates expression of the multiple sclerosis severity modifier D-dopachrome tautomerase in a sex-specific way. BioMed research international, 2018.

Vincent, F. B., Lin, E., Sahhar, J., Ngian, G. S., Kandane‐Rathnayake, R., Mende, R., ... & Harris, J. (2018). Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis. Clinical & translational immunology, 7(12), e1042.

Roger, T., Schlapbach, L. J., Schneider, A., Weier, M., Wellmann, S., Marquis, P., ... & Giannoni, E. (2017). Plasma levels of macrophage migration inhibitory factor and d-dopachrome tautomerase show a highly specific profile in early life. Frontiers in immunology, 8, 26.

Iwata, T., Kuribayashi, K., Nakasono, M., Saito-Tarashima, N., Minakawa, N., Mizusawa, N., ... & Yoshimoto, K. (2017). The AMPK/mTOR pathway is involved in D-dopachrome tautomerase gene transcription in adipocytes differentiated from SGBS cells, a human preadipocyte cell line. Cytokine, 96, 195-202.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols